MedPath

4-week continuous skin environmental improvement test of Blue rose extract powder capsule and placebo products

Not Applicable
Conditions
o
Registration Number
JPRN-UMIN000050470
Lead Sponsor
KINJIRUSHI Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
47
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects with a skin disease such as psoriasis. 2. Subjects with a skin disease such as atopic dermatitis. 3. Subjects taking medications or applying medicines topically that are likely to affect the test results. 4. Subjects with contact allergy or who might exhibit an allergic symptom. 5. Subjects who are undergoing dermatological treatment. 6. Subjects with eczema, rash, sunburn, fleck, or scratch marks on the site of the skin test. 7. Subjects who are pregnant or likely to be, or those who are breast feeding. 8. Subjects who participate in, at the time of initiation of this study, another test that interferes with this study or subjects who are scheduled to attend, during the tests, another test that interferes with this study. 9. Subjects who have tattoos, tattoo stickers, body paints, etc. on the site of the skin test. 10. Subjects who received chemical peel, laser treatment, light irradiation treatment, skin treatment such as injection, or surgery, or beauty therapy on the site of the skin test within 4 weeks by the start of the test. 11. Subjects who are judged as unsuitable by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Skin hydration in stratum corneum and trans epidermal water loss.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath